Garden State Investment Advisory Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$494K Buy
20,511
+1,158
+6% +$30.3K 0.09% 177
2026
Q1
$544K Buy
19,353
+2,263
+13% +$60.2K 0.12% 147
2025
Q4
$426K Sell
17,090
-2,302
-12% -$58.1K 0.09% 176
2025
Q3
$494K Sell
19,392
-10,212
-34% -$252K 0.11% 155
2025
Q2
$718K Buy
29,604
+9,648
+48% +$225K 0.18% 110
2025
Q1
$506K Buy
19,956
+743
+4% +$19.4K 0.16% 122
2024
Q4
$510K Sell
19,213
-405
-2% -$11K 0.15% 119
2024
Q3
$568K Buy
19,618
+385
+2% +$11.2K 0.18% 106
2024
Q2
$538K Buy
19,233
+1,634
+9% +$45K 0.19% 106
2024
Q1
$488K Buy
17,599
+5,001
+40% +$139K 0.18% 113
2023
Q4
$363K Buy
12,598
+328
+3% +$9.91K 0.14% 135
2023
Q3
$407K Buy
12,270
+3,618
+42% +$128K 0.19% 107
2023
Q2
$317K Buy
8,652
+585
+7% +$22.8K 0.12% 138
2023
Q1
$329K Sell
8,067
-53
-0.7% -$2.29K 0.14% 127
2022
Q4
$416K Buy
+8,120
New +$389K 0.25% 97

Other funds holding PFE

Garden State Investment Advisory Services's PFE Position: Q2 2026 in Review

Garden State Investment Advisory Services increased its Pfizer (PFE) stake by 6% in Q2 2026, buying an estimated $30.3K and bringing the position to 20,511 shares worth $494K. The position accounts for 0.09% of the portfolio, ranked #177.

Garden State Investment Advisory Services first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $718K in Q2 2025. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Garden State Investment Advisory Services held 20,511 shares of Pfizer worth $494K as of Q2 2026.
  • Garden State Investment Advisory Services bought 1,158 Pfizer shares in Q2 2026, an estimated $30.3K.
  • Pfizer made up 0.09% of Garden State Investment Advisory Services's portfolio in Q2 2026, its #177 holding.
  • Garden State Investment Advisory Services first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
  • Garden State Investment Advisory Services's Pfizer position peaked at $718K in Q2 2025.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Garden State Investment Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.